65.80
price down icon0.71%   -0.47
after-market  After Hours:  65.80 
loading
Henry Schein Inc. stock is currently priced at $65.80, with a 24-hour trading volume of 722.61K. It has seen a -0.71% decreased in the last 24 hours and a -9.58% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $65.94 pivot point. If it approaches the $65.37 support level, significant changes may occur.
Previous Close:
$66.27
Open:
$65.79
24h Volume:
722.61K
Market Cap:
$8.43B
Revenue:
$12.45B
Net Income/Loss:
$388.00M
P/E Ratio:
19.24
EPS:
3.42
Net Cash Flow:
$473.00M
1W Performance:
-3.96%
1M Performance:
-9.58%
6M Performance:
-12.57%
1Y Performance:
-12.04%
1D Range:
Value
$65.22
$66.25
52W Range:
Value
$60.01
$82.63

Henry Schein Inc. Stock (HSIC) Company Profile

Name
Name
Henry Schein Inc.
Name
Phone
631-843-5500
Name
Address
135 Duryea Road, Melville, NY
Name
Employee
22,000
Name
Twitter
@henryschein
Name
Next Earnings Date
2024-06-11
Name
Latest SEC Filings
Name
HSIC's Discussions on Twitter

Henry Schein Inc. Stock (HSIC) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-12-23 Upgrade JP Morgan Neutral → Overweight
Nov-10-23 Upgrade Stifel Hold → Buy
Aug-08-22 Upgrade UBS Sell → Neutral
Jul-21-22 Downgrade Goldman Buy → Neutral
Jun-14-22 Downgrade Robert W. Baird Outperform → Neutral
May-13-22 Resumed Credit Suisse Outperform
Jan-31-22 Initiated Morgan Stanley Underweight
Jan-07-22 Upgrade Credit Suisse Neutral → Outperform
Oct-01-21 Resumed Credit Suisse Neutral
Feb-08-21 Resumed Piper Sandler Overweight
Jan-04-21 Upgrade Robert W. Baird Neutral → Outperform
Nov-03-20 Upgrade Barrington Research Mkt Perform → Outperform
May-06-20 Downgrade Barrington Research Outperform → Mkt Perform
Apr-07-20 Upgrade Goldman Neutral → Buy
Apr-02-20 Upgrade Wolfe Research Peer Perform → Outperform
Jan-09-20 Downgrade BofA/Merrill Neutral → Underperform
Jan-02-20 Upgrade Evercore ISI Underperform → In-line
Aug-07-19 Downgrade William Blair Outperform → Mkt Perform
May-30-19 Initiated Wolfe Research Underperform
May-15-19 Downgrade SVB Leerink Outperform → Mkt Perform
Apr-18-19 Initiated Guggenheim Buy
Jan-17-19 Initiated UBS Sell
Jan-03-19 Downgrade Evercore ISI In-line → Underperform
Jan-02-19 Downgrade Robert W. Baird Outperform → Neutral
Nov-08-18 Reiterated Barrington Research Outperform
Oct-25-18 Downgrade Edward Jones Hold → Sell
Oct-19-18 Resumed Goldman Neutral
Oct-04-18 Reiterated Robert W. Baird Outperform
Aug-07-18 Reiterated Stifel Hold
Apr-24-18 Downgrade Goldman Buy → Neutral
Apr-04-18 Upgrade Leerink Partners Mkt Perform → Outperform
View All

Henry Schein Inc. Stock (HSIC) Financials Data

Henry Schein Inc. (HSIC) Revenue 2024

HSIC reported a revenue (TTM) of $12.45 billion for the quarter ending March 31, 2024, a -0.61% decline year-over-year.
loading

Henry Schein Inc. (HSIC) Net Income 2024

HSIC net income (TTM) was $388.00 million for the quarter ending March 31, 2024, a -18.83% decrease year-over-year.
loading

Henry Schein Inc. (HSIC) Cash Flow 2024

HSIC recorded a free cash flow (TTM) of $473.00 million for the quarter ending March 31, 2024, a +22.22% increase year-over-year.
loading

Henry Schein Inc. (HSIC) Earnings per Share 2024

HSIC earnings per share (TTM) was $2.97 for the quarter ending March 31, 2024, a -15.62% decline year-over-year.
loading
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides animal health products, such as branded and generic pharmaceuticals, surgical and consumable products and services, and equipment; and medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners, and animal health clinics. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners. The company was founded in 1932 and is headquartered in Melville, New York.
$22.63
price down icon 1.07%
medical_distribution OMI
$16.70
price up icon 0.00%
$8.99
price down icon 1.53%
$5.38
price up icon 1.17%
medical_distribution AHG
$0.742
price down icon 2.37%
Cap:     |  Volume (24h):